Press Release

Endocrine Society Applauds USPSTF for Type 2 Diabetes Screening Recommendations

October 07, 2014

USPSTF recommendations bolstered by new scientific evidence showing benefit to measuring blood glucose in adults at risk for diabetes

Washington, DC—The U.S. Preventive Services Task Force (USPSTF) posted yesterday a draft recommendation statement and draft evidence review on screening for abnormal glucose and Type 2 diabetes mellitus. The task force recommended screening for abnormal glucose and Type 2 diabetes in all adults over the age of 45. The Society participated in the review of the recommendations and supports the final recommendation statement.

In the statement, the USPSTF identified risk factors for impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and diabetes, including modifiable risks such as obesity, physical inactivity, and smoking and non-modifiable risk factors such as increasing age, race/ethnicity, a genetic predisposition to insulin resistance, a first-degree relative with diabetes and, in women, a history of gestational diabetes or polycystic ovarian syndrome.

“The Endocrine Society applauds and fully supports the USPSTF’s new diabetes screening recommendations to include measuring blood glucose for adults at increased risk for diabetes,” said Robert A. Vigersky, MD, past-president of the Endocrine Society and director of the Diabetes Institute at Walter Reed National Military Medical Center. “It’s critical to identify people with undiagnosed diabetes and risk factors for diabetes to allow for early interventions to prevent or delay the disease and its complications.”

Prior to yesterday’s statement, the USPSTF recommended screening for Type 2 diabetes only in asymptomatic adults with high systolic blood pressure (SBP > 130mmHg). The new recommendations take into account recent scientific evidence that shows measuring blood glucose in adults at increased risk for diabetes and treating those who have IFG or IGT with intensive lifestyle interventions has a moderate benefit in decreasing the risk for progression to diabetes.

Lifestyle modifications may include improved nutrition, healthy eating behaviors and increased physical activity. The USPSTF found adequate evidence that intensive lifestyle modifications result in a lower incidence of diabetes, cardiovascular mortality and all-cause mortality. In rating the level of evidence for screening a “B”, such screening qualifies as a covered preventive service without cost-sharing under the Affordable Care Act. 

The Endocrine Society’s membership includes physicians who care for people with diabetes as well as researchers who study the condition. The rising number of diabetes cases is a critical issue. More than 29 million people nationwide have diabetes, including an estimated 8.1 million don’t know they have the condition, according to the U.S. Centers for Disease Control and Prevention. Nearly half of endocrinologists’ office visits involved treating people with diabetes, according to the Society’s workforce analysis published in June.

About Endocrine Society

Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world’s oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

The Society has more than 18,000 members, including scientists, physicians, educators, nurses, and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at Follow us on X (formerly Twitter) at @TheEndoSociety and @EndoMedia.

Media Contacts

Colleen Williams Senior Communications Manager, Public Relations Phone: (202)-971-3611 [email protected]

Jenni Glenn Gingery Director, Communications and Media Relations Phone: (202)-971-3655 [email protected]

Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.